Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
202 studies found for:    "Aplastic anemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Aplastic anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
2 Recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
3 Unknown  Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cy-ATG;   Drug: Flu-ATG
4 Completed Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
5 Terminated
Has Results
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
6 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
7 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
8 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
9 Unknown  Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
10 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
11 Completed Combination Therapy of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Cyclosporine
12 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
13 Completed Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Sirolimus (Rapamune)
14 Completed Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Procedure: CD3±CD19 depleted hematopoietic stem cell transplantation
15 Completed Oral Manifestations of Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
16 Unknown  Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: rabbit antithymocyte globulin
17 Recruiting Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Rabbit antithymoglobulin (ATG);   Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs);   Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs)
18 Completed Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
19 Recruiting The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Procedure: IST;   Biological: cord blood transfusion;   Drug: Thymoglobuline® and oral CSA
20 Unknown  Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
Condition: Aplastic Anemia and Other Marrow Failure Syndrome
Intervention: Other: Database

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.